LIMN — Liminatus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Liminatus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.61 | -2.93 | -4.98 | -3.55 | -10.2 |
| Depreciation | |||||
| Non-Cash Items | 2.4 | 0.9 | 0 | — | 7.23 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.05 | 1.16 | 1.64 | 2.1 | -6.98 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.168 | -0.869 | -3.35 | -1.45 | -9.96 |
| Capital Expenditures | — | — | — | — | -0.013 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0 | -0.819 | -2.85 | -0.775 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | 0 | -0.819 | -2.85 | -0.788 |
| Financing Cash Flow Items | — | — | — | — | -2.56 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 5.92 | -0.45 | 3.92 | 11 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.168 | 5.05 | -4.61 | -0.378 | 0.281 |